Compile Data Set for Download or QSAR
Report error Found 48 Enz. Inhib. hit(s) with all data for entry = 50036017
TargetRenin(Human)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006848(CHEMBL88091 | N-[2-(2-Amino-thiazol-4-yl)-1-(1-cyc...)
Affinity DataIC50: 0.160nMAssay Description:Compound was evaluated for inhibition of plasma renin activity in humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetRenin(Human)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006850(CHEMBL313063 | N-[1-(1-Cyclohexylmethyl-2,3-dihydr...)
Affinity DataIC50: 0.200nMAssay Description:Compound was evaluated for inhibition of plasma renin activity in humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetRenin(Human)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006858(CHEMBL315380 | N-[1-(1-Cyclohexylmethyl-2,3-dihydr...)
Affinity DataIC50: 0.230nMAssay Description:Compound was evaluated for inhibition of plasma renin activity in humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetRenin(Human)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006854(CHEMBL88069 | N-[2-(2-Amino-thiazol-4-yl)-1-(1-cyc...)
Affinity DataIC50: 0.270nMAssay Description:Compound was evaluated for inhibition of plasma renin activity in humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetRenin(Human)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006853(CHEMBL315211 | N-(1-Cyclohexylmethyl-2,3-dihydroxy...)
Affinity DataIC50: 0.280nMAssay Description:Compound was evaluated for inhibition of plasma renin activity in humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetRenin(Human)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006845(CHEMBL316208 | N-[2-(2-Amino-thiazol-4-yl)-1-(1-cy...)
Affinity DataIC50: 0.350nMAssay Description:Compound was evaluated for inhibition of plasma renin activity in humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetRenin(Human)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006844(CHEMBL34894 | N-[2-(2-Amino-thiazol-4-yl)-1-(1-cyc...)
Affinity DataIC50: 0.360nMAssay Description:In vitro inhibition of monkey renin.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetRenin(Human)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006844(CHEMBL34894 | N-[2-(2-Amino-thiazol-4-yl)-1-(1-cyc...)
Affinity DataIC50: 0.370nMAssay Description:Compound was evaluated for inhibition of plasma renin activity in monkeyMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetRenin(Human)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006851(CHEMBL263531 | N-[1-(1-Cyclohexylmethyl-2,3-dihydr...)
Affinity DataIC50: 0.480nMAssay Description:Compound was evaluated for inhibition of plasma renin activity in humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetRenin(Human)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006856(4-{3-(2-Amino-thiazol-4-yl)-2-[2-(morpholine-4-sul...)
Affinity DataIC50: 0.5nMAssay Description:Compound was evaluated for inhibition of plasma renin activity in humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetRenin(Human)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006846(CHEMBL431217 | 4-{3-(2-Amino-thiazol-4-yl)-2-[2-(m...)
Affinity DataIC50: 0.540nMAssay Description:Compound was evaluated for inhibition of plasma renin activity in humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetRenin(Human)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006844(CHEMBL34894 | N-[2-(2-Amino-thiazol-4-yl)-1-(1-cyc...)
Affinity DataIC50: 0.570nMAssay Description:Compound was evaluated for inhibition of plasma renin activity in humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetRenin(Human)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006843(CHEMBL314066 | N-[(2-Amino-thiazol-4-yl)-(1-cycloh...)
Affinity DataIC50: 0.581nMAssay Description:Compound was evaluated for inhibition of plasma renin activity in humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetRenin(Human)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006849(CHEMBL430634 | 4-{3-(2-Amino-thiazol-4-yl)-2-[2-(m...)
Affinity DataIC50: 0.590nMAssay Description:Compound was evaluated for inhibition of plasma renin activity in humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetRenin(Human)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006202(A-64662 | CHEMBL300337 | 3-Amino-N-[1-[1-(1-cycloh...)
Affinity DataIC50: 0.760nMAssay Description:Compound was evaluated for inhibition of plasma renin activity in humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetRenin(Human)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM17941((2S,4S,5S)-5-[(2S)-2-[(2S)-2-benzyl-3-[(2-methylpr...)
Affinity DataIC50: 0.830nMAssay Description:Compound was evaluated for inhibition of plasma renin activity in humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetRenin(Human)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006860(CHEMBL85672 | {1-[2-(2-Amino-thiazol-4-yl)-1-(1-cy...)
Affinity DataIC50: 0.910nMAssay Description:Compound was evaluated for inhibition of plasma renin activity in humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetRenin(Human)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006844(CHEMBL34894 | N-[2-(2-Amino-thiazol-4-yl)-1-(1-cyc...)
Affinity DataIC50: 2nMAssay Description:Compound was evaluated for inhibition of plasma renin activity in dogMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetRenin(Human)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006864(CHEMBL420417 | {1-[2-(2-Amino-thiazol-4-yl)-1-(1-c...)
Affinity DataIC50: 2.30nMAssay Description:Compound was evaluated for inhibition of plasma renin activity in humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetRenin(Human)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006859(2-((R)-(S)-Morpholine-4-sulfonyl)-1,2,3,4-tetrahyd...)
Affinity DataIC50: 2.70nMAssay Description:Compound was evaluated for inhibition of plasma renin activity in humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetRenin(Human)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006861(CHEMBL315992 | 4-{3-(2-Amino-thiazol-4-yl)-2-[2-(m...)
Affinity DataIC50: 3.40nMAssay Description:Compound was evaluated for inhibition of plasma renin activity in humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetRenin(Human)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006857(CHEMBL316218 | 4-{3-(2-Amino-thiazol-4-yl)-2-[2-(m...)
Affinity DataIC50: 3.60nMAssay Description:Compound was evaluated for inhibition of plasma renin activity in humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetRenin(Human)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006852(CHEMBL87389 | 4-(2-Amino-thiazol-4-yl)-N-(1-cycloh...)
Affinity DataIC50: 4.10nMAssay Description:Compound was evaluated for inhibition of plasma renin activity in humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetRenin(Human)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006862(CHEMBL316176 | 4-{3-(2-Amino-thiazol-4-yl)-2-[2-(m...)
Affinity DataIC50: 14nMAssay Description:Compound was evaluated for inhibition of plasma renin activity in humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetCathepsin D(Bovine)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006860(CHEMBL85672 | {1-[2-(2-Amino-thiazol-4-yl)-1-(1-cy...)
Affinity DataIC50: 33nMAssay Description:Compound was evaluated for the percent inhibition of Cathepsin D in BovineMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetRenin(Human)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006847(CHEMBL86374 | N-[2-(2-Amino-thiazol-4-yl)-1-(1-cyc...)
Affinity DataIC50: 33nMAssay Description:Compound was evaluated for inhibition of plasma renin activity in humanMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetCathepsin D(Bovine)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006853(CHEMBL315211 | N-(1-Cyclohexylmethyl-2,3-dihydroxy...)
Affinity DataIC50: 35nMAssay Description:Compound was evaluated for the percent inhibition of Cathepsin D in BovineMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetCathepsin D(Bovine)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006843(CHEMBL314066 | N-[(2-Amino-thiazol-4-yl)-(1-cycloh...)
Affinity DataIC50: 86nMAssay Description:Compound was evaluated for the percent inhibition of Cathepsin D in BovineMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetCathepsin D(Bovine)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006850(CHEMBL313063 | N-[1-(1-Cyclohexylmethyl-2,3-dihydr...)
Affinity DataIC50: 130nMAssay Description:Compound was evaluated for the percent inhibition of Cathepsin D in BovineMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetRenin(Rat)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006844(CHEMBL34894 | N-[2-(2-Amino-thiazol-4-yl)-1-(1-cyc...)
Affinity DataIC50: 199nMAssay Description:Compound was evaluated for inhibition of plasma renin activity in ratMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetCathepsin D(Bovine)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006851(CHEMBL263531 | N-[1-(1-Cyclohexylmethyl-2,3-dihydr...)
Affinity DataIC50: 270nMAssay Description:Compound was evaluated for the percent inhibition of Cathepsin D in BovineMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetCathepsin D(Bovine)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006864(CHEMBL420417 | {1-[2-(2-Amino-thiazol-4-yl)-1-(1-c...)
Affinity DataIC50: 763nMAssay Description:Compound was evaluated for the percent inhibition of Cathepsin D in BovineMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetCathepsin D(Bovine)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006852(CHEMBL87389 | 4-(2-Amino-thiazol-4-yl)-N-(1-cycloh...)
Affinity DataIC50: 834nMAssay Description:Compound was evaluated for the percent inhibition of Cathepsin D in BovineMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetCathepsin D(Bovine)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006844(CHEMBL34894 | N-[2-(2-Amino-thiazol-4-yl)-1-(1-cyc...)
Affinity DataIC50: 1.25E+3nMAssay Description:Compound was evaluated for the percent inhibition of Cathepsin D in BovineMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetCathepsin D(Bovine)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM17941((2S,4S,5S)-5-[(2S)-2-[(2S)-2-benzyl-3-[(2-methylpr...)
Affinity DataIC50: 1.38E+3nMAssay Description:Compound was evaluated for the percent inhibition of Cathepsin D in BovineMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetCathepsin D(Bovine)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006845(CHEMBL316208 | N-[2-(2-Amino-thiazol-4-yl)-1-(1-cy...)
Affinity DataIC50: 2.17E+3nMAssay Description:Compound was evaluated for the percent inhibition of Cathepsin D in BovineMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetCathepsin D(Bovine)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006856(4-{3-(2-Amino-thiazol-4-yl)-2-[2-(morpholine-4-sul...)
Affinity DataIC50: 3.70E+3nMAssay Description:Compound was evaluated for the percent inhibition of Cathepsin D in BovineMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetCathepsin D(Bovine)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006846(CHEMBL431217 | 4-{3-(2-Amino-thiazol-4-yl)-2-[2-(m...)
Affinity DataIC50: 6.40E+3nMAssay Description:Compound was evaluated for the percent inhibition of Cathepsin D in BovineMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetCathepsin D(Bovine)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006848(CHEMBL88091 | N-[2-(2-Amino-thiazol-4-yl)-1-(1-cyc...)
Affinity DataIC50: 8.90E+3nMAssay Description:Compound was evaluated for the percent inhibition of Cathepsin D in BovineMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetCathepsin D(Bovine)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006847(CHEMBL86374 | N-[2-(2-Amino-thiazol-4-yl)-1-(1-cyc...)
Affinity DataIC50: 1.45E+4nMAssay Description:Compound was evaluated for the percent inhibition of Cathepsin D in BovineMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetCathepsin D(Bovine)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006857(CHEMBL316218 | 4-{3-(2-Amino-thiazol-4-yl)-2-[2-(m...)
Affinity DataIC50: 2.50E+4nMAssay Description:Compound was evaluated for the percent inhibition of Cathepsin D in BovineMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetCathepsin D(Bovine)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006859(2-((R)-(S)-Morpholine-4-sulfonyl)-1,2,3,4-tetrahyd...)
Affinity DataIC50: 3.00E+4nMAssay Description:Compound was evaluated for the percent inhibition of Cathepsin D in BovineMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetPepsin A(Pig)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM17941((2S,4S,5S)-5-[(2S)-2-[(2S)-2-benzyl-3-[(2-methylpr...)
Affinity DataIC50: 3.27E+4nMAssay Description:Compound was evaluated for the percent inhibition of pepsinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetCathepsin D(Bovine)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006858(CHEMBL315380 | N-[1-(1-Cyclohexylmethyl-2,3-dihydr...)
Affinity DataIC50: 5.18E+4nMAssay Description:Compound was evaluated for the percent inhibition of Cathepsin D in BovineMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetCathepsin D(Bovine)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006849(CHEMBL430634 | 4-{3-(2-Amino-thiazol-4-yl)-2-[2-(m...)
Affinity DataIC50: 9.50E+4nMAssay Description:Compound was evaluated for the percent inhibition of Cathepsin D in BovineMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetPepsin A(Pig)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006202(A-64662 | CHEMBL300337 | 3-Amino-N-[1-[1-(1-cycloh...)
Affinity DataIC50: 1.00E+5nMAssay Description:Compound was evaluated for the percent inhibition of pepsinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetCathepsin D(Bovine)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006202(A-64662 | CHEMBL300337 | 3-Amino-N-[1-[1-(1-cycloh...)
Affinity DataIC50: 1.00E+5nMAssay Description:Compound was evaluated for the percent inhibition of Cathepsin D in BovineMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed
TargetPepsin A-5(Human)
Parke-Davis Pharmaceutical Research Division of Warner-Lambert

Curated by ChEMBL
LigandPNGBDBM50006844(CHEMBL34894 | N-[2-(2-Amino-thiazol-4-yl)-1-(1-cyc...)
Affinity DataIC50: 2.02E+5nMAssay Description:Inhibitory activity against pepsin.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/22/2012
Entry Details Article
PubMed